Dobutamine stress tetrofosmin SPECT; evaluation of short rest-stress protocol and head to head comparison with MIBI in detection of coronary artery disease

Annals of Nuclear Medicine

Volumn 19, Issue 2, 2005, Pages 115-122

  Turgut, Bulent ^a,c   Unlu, Mustafa ^b   Cengel, Atiye ^b  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Dobutamine; Sestamibi; SPECT; Tetrofosmin

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; TRACER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOBUTAMINE STRESS TEST; EXERCISE TEST; FEASIBILITY STUDY; FEMALE; HEART PERFUSION; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SHORT REST STRESS PROTOCOL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TREADMILL ERGOMETRY; VASODILATATION;

EID: 19744373383     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03027390     Document Type: Article

References (21)

1. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m tetrofosmin: myocardial imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
2. Jain D. Technetium-99m labelled myocardial perfusion imaging agents. Cardiovascular nuclear medicine, part 1. Semin Nucl Med 1999; 29: 221-236.
3. Ravizzini GC, Hanson MW, Shaw LK, Wong TZ, Hagge RJ, Paganelli RA, et al. Efficiency comparison between Tc-99m tetrofosmin and Tc-99m sestamibi myocardial perfusion studies. Nucl Med Commun 2002; 23: 203-208.
4. Nakamura K, Sammiya T, Hashimoto J, Ishibashi R, Matsumoto K, Kubo A. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells. Ann Nucl Med 1996; 10: 375-381.
5. Matsunari I, Taki J, Nakajima K, Tonami N, Hisada K. Myocardial viability assessment using nuclear imaging. Ann Nucl Med 2003; 17: 169-179.
6. Matsunari I, Haas F, Nguyen NTB, Reidel G, Wolf I, Senekowitsch-Schmidtke R, et al. Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium. J Nucl Med 2001; 42: 818-823.
7. Schaefer WM, Moka D, Brockmann HA, Schomaecker K, Schicha H. Tl-201, Tc-99m MIBI, Tc-99m tetrofosmin and Tc-99m furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. Nucl Med Biol 2002; 29: 243-254.
8. Unlu M, Turgut B, Günaydin S, Atavci S, Gökgöz L. Dobutamine Tc-99m tetrofosmin SPECT in the detection of coronary artery disease: Evaluation of a same day rest-stress protocol. [Abstract] J Nucl Med 1995; 36 (Suppl): 132 P-No. 606.
9. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993; 21: 1583-1590.
10. Krivokapich J, Huang SC, Schelben HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993; 71: 1351-1356.
11. Mason JR, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, et al. Thallium scintigraphy during dobutamine infusion: Nonexercise-dependent screening test for coronary disease. Am Heart J 1984; 107: 481-485.
12. Turgut B, Unlu M, Temiz NH, Kitapci M, Alkan ML. Dobutamine Tc-99m furifosmine SPECT in detection of coronary artery disease: evaluation of same day, rest-stress protocol. Ann Nucl Med 2003; 17: 531-539.
13. Günalp B, Dokumaci B, Uyan C, Vardareli E, Isik E, Bayhan H, et al. Value of dobutamine Technetium-99m sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med 1993; 34: 889-894.
14. Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress Technetium-99m-sestamibi SPECT: Definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993; 34: 1494-1502.
15. Bavelaar-Croon CDL, Wahba FFMF, Van Hecke MV, Atsma DE, Stokkel MPM, Pauwels EKJ, et al. Perfusion and functional abnormalities outside the septal region in patients with left bundle branch block assessed with gated SPECT. Q J Nucl Med 2001; 45: 108-114.
16. Johansen A, Gaster AL, Veje A, Thayssen P, Haghfelt T, Hoilund-Carlsen PF. Interpretive intra- and interobserver reproducibility of rest/stress Tc-99m sestamibi myocardial perfusion SPECT in a consecutive group of male patients with stable angina pectoris before and after percutaneous transluminal angioplasty. Nucl Med Commun 2001; 22: 531-537.
17. Rigo P, Benoit T, Foulon J. Myocardial perfusion imaging: Imaging protocols. In: Myocardial perfusion imaging: an update. The Medicine Publishing Foundation Symposium Series, Number 34. Oxford, UK; The Medicine Group (Education) Ltd., 1994: 13-19.
18. Watson DD. Methods for detection of myocardial viability and ischemia (Chapter 6). Image Display and analysis (Section II). Nuclear Cardiology State of the Art and Future Directions. Zaret BL, Beller GA (eds), St. Louis, Missouri; Mosby-Year Book Inc., 1993: 65-76.
19. Wackers FJ Th, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
20. Higley B, Smith FW, Smith T, Gemmel HG, Gupta PD, Gvozdanovic DV, et al. Technetium-99m 1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-38.
21. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m- tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39: 266-271.